MICRA¿ VR2
Report
- Report Number
- 9612164-2025-04810
- Event Type
- Injury
- Date Received
- September 30, 2025
- Date of Event
- September 29, 2025
- Report Date
- September 30, 2025
- Manufacturer
- MEDTRONIC IRELAND
- Product Code
- PNJ
- PMA / PMN Number
- P150033
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AS
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
SECTION D REFERENCES THE MAIN COMPONENT OF THE SYSTEM. OTHER MEDICAL PRODUCTS IN USE DURING THE EVENT INCLUDE: BRAND NAME [MICRA] PRODUCT ID [MC2VR01-DELSYS] (SERIAL: (B)(6). D9: NO MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.
IT WAS REPORTED DURING IMPLANT OF THE LEADLESS IMPLANTABLE PULSE GENERATOR (IPG), DURING POSITIONING OF THE DELIVERY SYSTEM (DS) AND CONTRAST INJECTION THERE WAS EVIDENCE OF CONTRAST IN THE PERICARDIUM. A PERICARDIAL EFFUSION OCCURRED AND THE PATIENT EXPERIENCED CARDIAC TAMPONADE FORM PERFORATION AND PERICARDIOCENTESIS WAS PERFORMED, DRAINING TWO HUNDRED AND FIFTY MILLILITERS OF FLUID. THE PATIENT WAS INTUBATED. THE LEADLESS IPG AND DS WERE ATTEMPTED/NOT USED. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1773508 | MICRA¿ VR2 | LEADLESS PACEMAKER | PNJ | MEDTRONIC IRELAND | MC2VR01 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female | Required Intervention| L| H |